3VZV | Ligase Ligase Inhibitor | date | Oct 16, 2012 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Human Mdm2 With A Dihydroimidazothiazol Inhibitor | ||||||||||||||
authors | H.Shimizu, S.Katakura, M.Miyazaki, H.Naito, Y.Sugimoto, H.Kawato, T.Okayama, T.Soga | ||||||||||||||
compound | source | ||||||||||||||
Molecule: E3 Ubiquitin-Protein Ligase Mdm2 Chain: A, B Fragment: Swib Domain, Unp Residues 25-109 Synonym: Double Minute 2 Protein, Hdm2, Oncoprotein Mdm2, P Protein Mdm2; Ec: 6.3.2.- Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Mdm2 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Bl21 Expression_system_vector_type: Plasmid Expression_system_plasmid: Pgex4t3 | ||||||||||||||
symmetry | Space Group: P 21 21 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.80 Å | ||||||||||||
ligand | VZV | enzyme | Ligase E.C.6.3.2 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Lead optimization of novel p53-MDM2 interaction inhibitors possessing dihydroimidazothiazole scaffold., Miyazaki M, Naito H, Sugimoto Y, Kawato H, Okayama T, Shimizu H, Miyazaki M, Kitagawa M, Seki T, Fukutake S, Aonuma M, Soga T, Bioorg Med Chem Lett. 2013 Feb 1;23(3):728-32. doi: 10.1016/j.bmcl.2012.11.091., Epub 2012 Dec 1. PMID:23266121 |
Data retrieval |
View 3VZV in 3D |
Visual 3D analysis of 3VZV |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3VZV |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |